Home » Business, Health & Medicine, Pharmaceuticals & Biotech, Science » Biosimilars Market Scope, Trends, Analysis, Growth and Regional Forecast to 2020
“Reportsweb”
Global Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator’s product. They have many similarities, but are not identical to, the reference biopharmaceutical product. 

Publisher’s analysts forecast the global biosimilars market to grow at a CAGR of 55.52% during the period 2016-2020.

Complete Report Available at: http://www.reportsweb.com/global-biosimilars-market-2016-2020 .

Covered in this report 

The report covers the present scenario and the growth prospects of the global biosimilars market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products such as somatropin, erythropoietin, colony-stimulating factors (CSF), interferons, interleukins, insulin and insulin analogs, follicle stimulating hormones (FSH), monoclonal antibodies (mAbs), and low molecular weight heparins (LMWH).

The market is divided into the following segments based on geography: 
– Americas
– APAC
– EMEA

Publisher’s report, Global Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
– Biocon 
– Celltrion 
– Dr. Reddy’s Laboratories 
– Hospira 
– Sandoz 
– STADA
– Teva Pharmaceuticals

Purchase this Premium Research Report at: http://www.reportsweb.com/buy&RW0001345914/buy/2500 . (Priced at US$ 2500)

Other prominent vendors 

– 3SBio
– Accord Healthcare
– AET Biotech
– Allergan
– Alvartis Pharma
– Amega Biotech
– Amgen
– Apotex
– Aspen
– AstraZeneca
– Aurobindo Pharma
– Baxter
– Bharat Serums
– Bio Sidus 
– Biogen
– Bionovis
– Bioton 
– BioXpress Therapeutics
– Boehringer Ingelheim
– Boston Oncology
– Cipla
– Coherus Biosciences
– Daiichi Sankyo
– Emcure Pharmaceuticals
– Gedeon Richter
– GeneScience Pharmaceuticals 
– GSK
– Hetero Drugs
– iBio 
– Intas Pharmaceuticals
– JCR Pharmaceuticals
– LG Lifesciences
– Lonza
– Merck
– Mitsubishi Tanabe Pharma
– Momenta Pharmaceuticals
– Mylan
– Natco Pharma
– Novartis
– Pfenex
– Pfizer
– Ranbaxy Laboratories 
– Roche Holding
– Samsung Biologics 
– Sanofi
– Synthon
– Wockhardt
– Zydus Cadila Healthcare

Get Sample Report at: http://www.reportsweb.com/inquiry&RW0001345914/sample     

Table of Contents:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Pipeline portfolio

PART 06: Market landscape

PART 07: Market segmentation by application

PART 08: Market segmentation by end-user

PART 09: Geographical segmentation

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

PART 16: Appendix

PART 17: Explore Publisher

Inquire about Report at: http://www.reportsweb.com/inquiry&RW0001345914/buying  

Media Contact
Company Name: ReportsWeb
Contact Person: Rajat Sahni
Email: sam@reportsweb.com
Phone: +1-646-491-9876
Country: United States
Website: http://www.reportsweb.com/global-biosimilars-market-2016-2020

Comments are closed.